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TheprojectHICARE:cross-sectoralactionallianceagainst
multi-resistant pathogens
Das Projekt HICARE: Sektorübergreifendes Aktionsbündnis gegen
multiresistente Erreger
Abstract
Multi-resistant pathogens are a serious problem on a considerable
scale for the health sector. Patients with infections induced by multi-
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by the Robert Koch Institute (RKI) include a presumption provision,
which means that subject to compliance with these guidelines the ob-
servance of the current state of medical science is suspected. In case 1 Scientific Institute of Benefit
and Efficiency (WINEG), of a derogation, a scientific justification is necessary, which is used e.g.
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in connection with liability questions. Within the framework of legal re-
forms in 2011, the legislator aspires a nationwide improvement of hy-
gienequalityinmedicalinstitutionsandinformationtransparency.Many 2 Faculty of Law and
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multi-resistant pathogens or about the standardized exchange of infec-
tion documentations between medical institution and health authority
remain unresolved. 3 Clinical Care Department,
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Regional, cross-sectoral networks create the base to tackle targeted
measures collectively and may develop sustainable and tailored solu-
tions for their region. With these considerations in mind, the project 4 State Representative Office
Mecklenburg-Pomerania, HICAREwasfoundedinMecklenburg-Vorpommern.Theprojectpursues
the aim to develop an intervention strategy against the spread of multi- Techniker Krankenkasse,
Schwerin, Germany resistantpathogens.Healthinsurancesmakeanimportantcontribution
to quality of medical treatment by participation.
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Zusammenfassung
Multiresistente Erreger (MRE) stellen ein ernstzunehmendes Problem
erheblichen Ausmaßes für den Gesundheitssektor dar. Patienten mit
MREinduziertenInfektionenverursachenimmensezusätzlicheBehand-
lungskostenvonrund20.500€proVersichertem.Aufgrunddesderzeit
genutzten pauschalen Abrechnungs- bzw. Dokumentationssystems
besteht ein erheblicher Mangel an Informationstransparenz. Die vom
Robert Koch-Institut (RKI) veröffentlichen Empfehlungen zur Kranken-
haushygieneundInfektionspräventionbeinhalteneinesog.Vermutungs-
regelung, d.h. bei ihrer Einhaltung wird vermutet, dass der Stand der
medizinischenWissenschaftbeachtetwordenist.ImFallderAbweichung
muss dafür eine wissenschaftliche Begründung gegeben werden, was
z.B. bei Haftungsfragen zugrunde gelegt wird. Im Rahmen gesetzlicher
Neuerungen strebt der Gesetzgeber 2011 eine bundesweite Verbesse-
rung der Hygienequalität in medizinischen Einrichtungen sowie der In-
formationstransparenz an. Viele konkrete Fragen über die allgemeine
Meldepflicht für Infektionen mit MRE oder über den standardisierten
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Einrichtung und Gesundheitsbehörde bleiben jedoch weiterhin offen.
Regionale,sektorübergreifendeNetzwerkeschaffendieBasis,Maßnah-
men gezielt im Team anzugehen und können auf diese Weise nachhal-
tige,fürihreRegionzugeschnitteneLösungenentwickeln.Unterdiesen
GesichtspunktenbildetesichauchdasProjektHICAREinMecklenburg-
Vorpommern heraus. Das Projekt verfolgt das Ziel, Interventionsstrate-
gien gegen die Ausbreitung von MRE zu entwickeln. Krankenkassen
leisten durch ihre Mitwirkung einen wichtigen Beitrag zur Versorgungs-
qualität.
Schlüsselwörter:Kostenanalyse,Staphylococcusaureus,Krankenkasse,
Projekt HICARE, Infektionsdokumentation, Infektionsschutzgesetz
Introduction
Bacterial multi-resistance of staphylococcus aureus
(MRSA), enterobacteria (ESBL) and other pathogens is a
serious problem for the treatment of infections. Such
multi-resistantbacteriaresultworldwideinseverewound
as well as surgical site infections, infections of the respi-
ratoryandurinarytract,inlife-threateningsystemicinfec-
tions (sepsis) or severe gastrointestinal impairment and
other diseases.
In Germany, every year 400,000 to 600,000 patients fall
illwithhospitalacquiredinfections(nosocomialinfections)
[1]. Nationwide, up to 15,000 people die from the con-
sequences of these infections [1]. Experts estimate that
at least one third of nosocomial infections are prevent-
able. In addition, there are infections with multi-resistant
microorganisms which are acquired outside of the hos-
pital, so-called “community acquired” MRSA (caMRSA).
The discussion about appropriate measures in the battle
against “hospital germs”, especially multi-resistant bac-
teria, stirs the German health care system currently be-
cause, according to the WHO, the observing spread of
multi-resistantbacteriainGermanysignifiestheentrance
in the post-antibiotic era, a period in which many infec-
tions are hardly or incurable like hundred years ago.
On the one hand infections with multi-resistant bacteria
strain the patients. Otherwise they menace Germany as
location of health and carry a financial risk for providers,
in particular hospitals. In consequence of generalized
billing with insurance companies and the currently insuf-
ficiently differentiated coding as well as the calculation
of flat-rates, the financial deficit remains partially with
the hospital.
Amonitoringofnosocomialinfectionswithmulti-resistant
bacteria by use of routine data of statutory health insur-
ance bases on diagnostic documentation and documen-
tation of realized operations or procedures. The system-
atic recording of infections with multi-resistant bacteria
is hampered by incomplete documentation in the hos-
pitals. This can't only be justified with the apprehension
ofstigmatizationbutisalsotheresultofeconomicincen-
tivesintheDRGsystem.TherecognitionofICD-diagnosis
and OPS-numbers with a reference to multi-resistant
bacteria could be abstained because of disincentive ef-
fects.
Method
In April 2011, the Scientific Institute of the Techniker
Krankenkasse (WINEG) analyzed inpatient numbers of
cases to quantify not documented infections with multi-
resistantpathogens.Onthebasisofdatasuppliedbythe
Charité, the expected (primary data) prevalence of infec-
tions with multi-resistant pathogens was projected onto
all insured people of the Techniker Krankenkasse (TK)
and was compared with the by OPS-Codes registered
(secondary data) prevalence of 7.8 million TK-insured.
Results
Quantification of not documented
infections
ThepreliminaryresultoftheTK-routine-datareviewshows
that, dependent from methodology, up to two thirds of
expected inpatient cases of multi-resistant pathogens
aren't documented. Hospital doctors confirm that the in-
completeness of hospital documentation refers first of
all to the appeal of optimizing profits in the existing DRG-
system [2].
Routine data of health insurances from the residential
sector are also billing data for relevant institutions. In
general, it must be assumed that the documentations
are always incomplete whereas diagnoses of hospital
discharge are considered as comparatively reliable. The
example of multi-resistant bacteria demonstrates that
completeness of ICD- and OPS-codes in the residential
sector must not be axiomatic implied. A quantification of
incorrect documentations enables the calculation of an
adequate correction factor.
If the exclusion of disincentive effects succeeds by virtue
of advancement of the DRG-system, the suitability of
routine data for incidence determination of nosocomial
infections as quality indicator is still to verify – not least
within the framework of selective contracts.
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In literature, some cost analysis are already to be found
which were all compiled from the hospitals' point of view
andrevealthatahospitalhasadeficitofaround6,000€
for the treatment of an infection by multi-resistant
pathogens.
Healthinsurancesareabletoassesscoursesoftreatment
and costs cross-sectoral. In the direct cost comparison
of inpatient stays of similar TK-insured regarding age,
gender and basic-DRG with and without multi-resistant
pathogens, it is recognizable that a total of 20,525 €
additional charges accrue per insured person. These ad-
ditional costs emerge primarily in the hospital (Figure 1)
but also the medication order occasions additional costs
of 1,600 € per insured (Figure 2). Further analysis is
planned making the severity of comorbidities in both
groups with and without multiresistant pathogens even
more comparable to prevent possible overestimation of
additional costs.
Figure 1: Costs of hospital stays including outpatient surgery
perinsuredwith(MRE+)andwithout(MRE-)infectionsinduced
by multi-resistant bacteria 2007–2009
Figure 2: Costs of pharmaceuticals per insured with (MRE+)
and without (MRE-) infections induced by multi-resistant
bacteria 2007–2009
It becomes apparent that there is no obvious increase of
additional costs over time (Figure 3). Allowing for preva-
lence rise and TK-insured growth, a huge increase of an-
nual additional costs can be ascertained all in all. There
is a need of reflection about which categories of insured
persons are generally affected by multi-resistant patho-
gens and how far these patients correspond to the clien-
tele of the TK. By far, the highest costs induced by multi-
resistant pathogens are caused by insured of lower age
groups(0to30years)(Figure4andFigure5).Thisascer-
tainment contrasts with comparable insured where a
higheragealsocorrelateswithhighercosts.Thepercent-
age of TK-insured persons under 30 years of more than
35 percent is above the German average of 31.8 percent
[3]. Furthermore, multi-resistant bacteria as a high cost
factor will be of great significance for the TK.
Figure 3: Total costs per insured with (MRE+) and without
(MRE-) infections induced by multi-resistant bacteria
2007–2009
Discussion
New documentation possibilities are
necessary
To ensure transparency about multi-resistant pathogens
inthemedicalprocesses,distinguishingfeaturesregard-
ing source of infection, gates and infection routes are
required.Thesecharacteristicsarethebasisforaquality-
assured medical care. Adaptations in the ICD and OPS
catalogbytheGermanInstituteofMedicalDocumentation
and Information (DIMDI) are necessary. Suggestions for
a differentiated coding have already been received, es-
pecially referring to the problem about the impossibility
of a sufficient differentiated coding of multi-resistant
pathogensinthevalidICD-10catalog.Anencodingabout
the acquisition of multi-resistant pathogens before hos-
pital stay or during inpatient service doesn't exist yet.
The Initiative of Quality Medicine (IQM) already proposed
the admission of a separate code for MRSA in February
2011 to make the pathogen codeable as well as to ar-
range a clear separation of the acquisition before or
during the current hospital stay. Documentations on this
basis enable the Institute for Hospital Reimbursement
System (InEK) which is responsible for advancement of
the DRG-system to project multi-resistant bacteria more
differentially in the DRG-system. This is ultimately the
only way to create conditions for higher reimbursement
for better care quality.
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Figure 5: Average additional costs per insured with infections induced by multi-resistant bacteria 2007–2009
Legal reforms
According to the Federal Ministry of Health, the problem
of the high infection and resistance rates is not the lack
ofrecommendationsbutrathertheinsufficientimplemen-
tation of applicable and published guidelines. The law
amending the Law of Infection Protection (IfSG) passed
in July 2011 should lay the foundations to improve the
quality of hospital hygiene. The reduction of infections
with multi-resistant pathogens is strongly emphasized.
This applies both to guidelines on an appropriate anti-
biotics therapy and prevention by the commission anti-
infectives, resistance and therapy (ART) and on infection
control in general by the commission of hospital hygiene
and infection prevention, both resident at the RKI.
Moreover, record keeping requirements for nosocomial
infections and resistant pathogens exist from now. A
standardizedexchangeofrecordinginformationbetween
medical institutions and the RKI isn't provided. The com-
pliance of hygiene standards in medical and dental
practices is considered in § 23(5) IfSG, however not ob-
ligatory at federal level. State governments can define
specific measures of infection hygiene in practices.
Until 31 March 2012, the state governments commit to
enactexecutiveorderlawsforthecomplianceofinfection
hygiene in institutions of health care. The legislator puts
provisionstobetakeninconcretetermsintheframework
of a ten-point catalog. Established physicians are more
involved in the flow of information by means of point ten
of § 23(8), thereby taking the principle “search and fol-
low”moreintoaccount.Accordingtothat,thecareshould
be effective and cross-sectoral along the whole “MRSA
supply chain” [4].
The law also provides to include the measured hygiene
quality of hospitals in their quality reports prospectively
toincreasetransparencyandcompetition.Thereimburse-
mentsystemhastosetincentivesforproviderstobehave
responsibly towards the identification of multi-resistant
pathogens,measuresfortreatmentandfortheprotection
of infected patients.
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“Visions need fantasy”, is the title of Heinz Lohmann's
publication about innovative projects in the health care
sector [5]. The vision of the project HICARE (Health, In-
novative Care and Regional Economy) is the effective
encounter of medical pathogens. The action alliance
against multi-resistant pathogens unifies in addition to
the TK also a variety further partner like BioCon Valley.
In this regional, on the German Baltic coast focused pro-
jecteffective,standardizedandtransferableintervention
strategiesshouldbedeveloped,attemptedandprepared
for the standard care. The project idea was chosen as
one of five winners in the contest “Health Regions in the
Future” from the Federal Ministry of Education and Re-
search (BMBF).
TheaspirationistoorganizethehealthregionBalticcoast
in such a way that it can serve as model region for the
whole of Germany related to the successful containment
of the spread of multi-resistant pathogens. The project
should foster the development in health industry of
Mecklenburg-Pomerania successively. In general, the
positivedevelopmentofthehealthindustryisdependent
from the mobilization of private and public resources.
Importantcircumstanceswerecreatedbyprojectfunding
recently. Start-up funding in the context of integrated
medicalcarewasacatalystforsuchprojectfoundations.
Conclusion
In the fight against “hospital germs” health insurances
are potential partners. From a competitive point of view,
considering mostly simplified health insurance contribu-
tions, insurances should seize the opportunity to cope
with competition by the supply of high-quality services.
Infection prevention and protection in the medical care
can entail a competitive advantage. Necessary condition
for comparability of service offerings of individual health
insurances is transparency of quality.
What concerns primarily in the future are common solu-
tions for patients between health service providers and
industry,inotherwordstoconsiderfightingthepathogens
asacollectiveconcept.Theintegratedmedicalcareoffers
a platform for committed partners in the health care
system.
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